China's SFDA Sets New GMP Standards
This article was originally published in PharmAsia News
Executive Summary
SHANGHAI -- China's State Food and Drug Administration issued revised good manufacturing practice regulations Oct. 24 in an effort to increase quality systems standards for pharmaceutical manufacturers. The new standards are scheduled to go into effect Jan. 1, replacing the current GMP standards, which were implemented in 1998